As a global biopharmaceutical company,our greatest contribution to society is making medicines that help people live longer, healthier, more active lives. This is the core of what we do. But our company vision – to improve global health in the 21st century – demands that we do even more. It call us to continue along our company’s distinguished path of giving back and lifting up in new and ever-better ways.
At Lilly, Corporate Social Responsibility (CSR) aligns business operations with social values: integrating the interest of all stakeholders into the company policies and actions. CSR focuses on the social, environmental and financial success of a company with the overarching goal of positively impacting the society, while achieving business success. It reinforces our commitment to operating ethically and fairly and with respect for the needs of local communities and of society at large.
Our work in India encompasses a variety of projects across the country. Find out more
Lilly MDR-TB Partnership
Formed in 2003, the Lilly MDR-TB Partnership seeks to increase the access and availability of MDR-TB treatments, while also improving education for healthcare professionals and raising awareness amongst communities most at risk. Lilly collaborates with its partner organizations working to improve outcomes for people who have multidrug-resistant tuberculosis (MDR-TB). Funded by the United Way Worldwide through a grant from the Eli Lilly and Company Foundation, the Lilly MDR-TB Partnership brings together government leaders, global health organizations, country-level healthcare providers, community and advocacy organizations and other stakeholders to increase the availability of quality-assured medicine used to treat MDR-TB, enhance education for healthcare professionals where the need is greatest, and raise awareness of the disease amongst communities most at risk.
In India, the MDR-TB Partnership works with organizations across five states to increase awareness, train healthcare providers and improve access to treatments. It also monitors program’s impacts and shares best practice around the globe. In collaboration with the Government of India’s Revised National TB Control Program (RNTCP) the Partnership has assisted in implementing the DOTS Plus Program in a number of states. It invests in training a range of health care providers- from nurses, chest physicians, pharmacists to community based volunteers to build their capacity and assist the National TB Control Program. It supports innovative use of mobile technology to reach the people in remote and difficult to reach areas and provide them access to the program. In collaboration with a non-profit organization the Partnership also offers Fellowships to journalists to undertake research on tuberculosis-related issues to raise awareness of the condition via the media, particularly regional language outlets.
Click here to find out more about The Lilly Multi Drug Resistant - Tuberculosis (MDR-TB) Partnership(PDF)
Lilly NCD Partnership (Uday)
Non-communicable diseases (NCDs) such as diabetes, cancer and cardiovascular diseases account for 63% of all deaths, and four-fifths of these deaths occur in low- and middle-income countries. In India 69.2 million people currently suffering from Diabetes(IDF Diabetes Atlas 2015)and the number is expected to raise upto123.5 million by 2040(IDF Diabetes Atlas 2015). That’s why we created the Lilly NCD Partnership, a global health program to fight the rising burden of NCDs in emerging economies through research, reporting, and advocacy model. The Lilly NCD Partnership is an extension of Lilly’s corporate responsibility efforts but is closely integrated with the company’s core therapeutic business expertise.
In India, Lilly launched project ‘Uday’ in 2012 (in partnership with PHFI,PSI and Project HOPE), an intensive five-year program aiming to fight the rising burden of non-communicable diseases in India ,with an initial focus on improving outcomes for people with diabetes and high blood pressure. Based on this unique research, report and advocate framework, this program aims to demonstrate a cost-effective scalable comprehensive model for prevention and management of diabetes and high blood pressure . Through this approach, the program will focus on sharing results with key stakeholders, including government and the global health community to encourage adoption of the best solutions. In the first phase, the project will be implemented in Vizag (Andhra Pradesh) and Sonepat (Haryana).
Click here to find out more about The Lilly NCD Partnership(PDF)
The reach of our responsibility programs is global. Yet right at the heart of Lilly is a commitment to invest in the local communities in which we operate. Across India, our employees are encouraged to take part in a wide range of programs that help us meet this commitment.
- Day of Service: Each October, about 20,000 Lilly employees spend a day out of the office, helping local communities around the world. Since the program launched in 2008, employees have given nearly 625,000 hours through Global Day of Service initiatives, making it one of the largest single-day volunteer programs in the world. Our employees volunteer across India upgrading sanitation facilities, refurbishing community centers, participating in blood donation camps, schooling underprivileged kids, helping in orphanages and working with disabled children.
- Step-up: As part of our commitment to our local community, Lilly is the corporate partner for a ‘Step-Up Centre’ in the Jharsa area, just 5 minutes’ walk from our office in Gurgaon. Step Up Centres give underprivileged children – many of whom are migrants - who are currently not enrolled in school an opportunity to receive a basic education, and prepare for joining a government school at their age appropriate level in the future. Alongside education, children and their families will also have the opportunity to learn about basic health and hygiene. As the corporate partner for the Jharsa Step Up project Lilly employees can volunteer time, energy, ideas and resources, working alongside the children and their families to improve the lives of those living in our local community.
Grants and Donations
Lilly strives to create and deliver innovative medicines that enable people to live longer, healthier and more active lives. As a component of this goal, Lilly is committed to supporting projects that promote excellence in patient care, healthcare delivery system or benefit and strengthen the given community.
Lilly India has for many years provided funding to organizations in the form of independent grants in response to unsolicited request for supporting medical education, patient awareness, and other worthy activities that we believe will increase healthcare knowledge and performance, resulting in better patient care and proactive charitable contributions to help alleviate conditions caused by natural disaster or humanitarian or health emergency.Click here to download the PDF.